Skip to main content
UKPMC Funders Author Manuscripts logoLink to UKPMC Funders Author Manuscripts
. Author manuscript; available in PMC: 2019 Aug 7.
Published in final edited form as: Proc Nutr Soc. 2019 Mar 22;78(3):426–437. doi: 10.1017/S0029665119000533

Effects of obesity and weight loss on mitochondrial structure and function and implications for colorectal cancer risk

SP Breininger 1,2,3,4, FC Malcomson 1,2,4, S Afshar 1,5, DM Turnbull 3,4, L Greaves 3,4, JC Mathers 1,2,3,4
PMCID: PMC6685789  EMSID: EMS81601  PMID: 30898183

Abstract

Colorectal cancer (CRC) is the third most common cancer globally. CRC risk is increased by obesity, and by its lifestyle determinants notably physical inactivity and poor nutrition. Obesity results in increased inflammation and oxidative stress which cause genomic damage and contribute to mitochondrial dysregulation and CRC risk. The mitochondrial dysfunction associated with obesity includes abnormal mitochondrial size, morphology and reduced autophagy, mitochondrial biogenesis and expression of key mitochondrial regulators. Although there is strong evidence that increased adiposity increases CRC risk, evidence for the effects of intentional weight loss on CRC risk is much more limited. In model systems, energy depletion leads to enhanced mitochondrial integrity, capacity, function and biogenesis but the effects of obesity and weight loss on mitochondria in the human colon are not known. We are using weight loss following bariatric surgery to investigate the effects of altered adiposity on mitochondrial structure and function in human colonocytes. In summary, there is strong and consistent evidence in model systems and more limited evidence in humans that over-feeding and/ or obesity result in mitochondrial dysfunction and that weight loss might mitigate or reverse some of these effects.

Keywords: Obesity, colorectal cancer, mitochondria, bariatric surgery

Colorectal cancer prevalence

Colorectal cancer (CRC) is the third most common cancer worldwide with approximately 1.4 million cases diagnosed in 2012 1. It is predicted that, by 2030, CRC will rise by 60% and that there will be over 2.2 million new cases 2. A qualitative analysis of 56 observational studies among 7, 213, 335 individuals and 93, 812 CRC cancer cases demonstrated that increased BMI was linked with higher CRC risk 3. Ning 3 and colleagues also showed that each 5 kg/m2 unit rise in BMI increased CRC risk by 18%. This association with BMI was stronger for colon than for rectal cancer and for males than for females 3. Additionally, obesity is a major risk factor for colorectal adenomas 4, suggesting that higher adiposity is a key player at early stages of colorectal tumorigenesis 5. Ma 6 and Keum 7 confirmed a linear dose-dependent relationship between abdominal/ visceral adiposity and risk of colorectal adenomas suggesting that excess body fatness in and around the visceral organs may explain the positive association observed between increased BMI, increased waist and hip circumference, and risk of colorectal adenomas and CRC.

Biology of colorectal cancer development

Most CRC develop sporadically and only 15-30% are due to inherited causes 8. CRC result from unrepaired genomic damage to stem cells and their progeny located in the crypts of the colorectal mucosa. Both epigenetic modifications and gene mutations contribute to CRC development by activating oncogenic pathways and by inactivating tumour suppressor genes 9. This genomic damage includes chromosomal defects, mutations in the nuclear and mitochondrial DNA and epigenetic abnormalities that lead to aberrant gene expression and uncontrolled growth of colonocytes. Through a Darwinian process, damage which provides the nascent tumour cell with a competitive advantage results in the development of cell clones with excessive proliferation and, therefore, neoplastic potential and leads to monocryptal adenomas or aberrant crypt foci. Crypt fission may expand such lesions resulting in the development of non-malignant growths known as adenomatous polyps 10. With further genetic and epigenetic changes causing hyperplasia, some adenoma develop into malignant adenocarcinoma and some, eventually, metastasise 8. Inactivating mutations in the tumour suppressor gene APC occur early in almost all CRCs. Loss of APC function results in aberrant expression of the WNT signalling pathway which contributes to increased cell proliferation and polyp development 11. In addition, mutations in KRAS or BRAF occur in 55-60% of CRC and the proto-oncogene, KRAS signals through BRAF to activate the mitogen-activated protein kinase (MAPK) pathway 11. Further mutations in KRAS or TP53, or in genes regulating key pathways such as the transforming growth factor-β (TGF-β1) signalling pathway, mediate the transformation from polyps to cancer 1215. Approximately 30% of CRC have mutations in the gene encoding the type 2 receptor for TGF-β (TGFBR2) 16, 17. Furthermore, other mutated TGF-β signalling pathway members including TSP1, RUNX3, SMAD2 and SMAD4 have been identified in CRC 14, 1721. Overall, the most frequently mutated genes in signalling pathways are found in the RAS-RAF-MAPK, WNT-APC-CTNNB1, PI3K and TGFβ1-SMAD pathways 22, 23.

Risk factors for CRC and role of obesity

CRC risk increases with age and is modified by lifestyle factors including physical activity, diet, smoking and obesity which influence the acquisition and repair of genomic damage 24, 25. Obesity, inflammation and CRC risk are inter-linked closely 5. In obesity, a range of pro-inflammatory cytokines and signalling molecules are secreted resulting in systemic low-level inflammation and increased reactive oxygen species (ROS), that accelerate genomic damage 26, 27. With increasing adiposity, leptin concentrations increase 28. This leads to higher TNF-α, IL-6 and -12 production and the accumulation of pro-inflammatory macrophages 28. Wei and colleagues 29 reported elevated plasma C-reactive protein (CRP), TNF-α and IL-6 concentrations in obese individuals, linked with impaired glucose tolerance, insulin resistance, abnormally high concentrations of insulin and insulin-like growth factor 1 (IGF-1), and low concentrations of IGF binding proteins, all of which may increase CRC risk. More studies reported that plasma CRP concentrations are correlated positively with CRC risk 3032. Faecal calprotectin concentration (a marker of mucosal inflammation) is positively correlated with obesity and inversely correlated with fibre, fruit and vegetable consumption 33. This obesity-derived inflammation initiates a mucosal signalling cascade which involves activation of the transcription factor NF-κB and higher expression of both inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) 34. This altered signalling may play a key role in suppression of apoptosis, which is a key feature of tumourigenesis 35.

Effects of weight loss on CRC risk and on biomarkers of CRC risk following lifestyle-based interventions

A systematic review and meta-analysis investigating the effects of weight change on CRC risk in 13 studies, found that weight gain was associated with increased CRC risk but that there was no association with weight loss 39. However, weight loss resulting from lifestyle-based interventions affects biomarkers of CRC risk including expression of inflammatory markers and cell proliferation. In the INTERCEPT Study, 14% weight loss via an 8-week low-energy liquid diet, in 20 obese adults resulted in reduced Ki-67 expression (a marker of cell proliferation) in the colorectal mucosa and improvements in insulin sensitivity; higher insulin resistance is a potential mechanism underlying the effects of obesity on CRC risk 40. Nicklas and colleagues 41 reported that weight loss after a low-energy diet reduced plasma concentrations of pro-inflammatory markers including CRP, TNF-α and IL-6 in obese older people (60+ years). Similarly, a low-energy diet in obese middle-aged women resulted in decreased expression of IL-6 and TNF-α in plasma and in subcutaneous adipose tissue 42. Although changes in inflammatory markers in plasma and adipose tissue may reflect changes in other tissues, measurements made in colorectal tissue per se are more directly relevant. Weight loss (mean 10.1% of initial body weight) resulting from a very-low-energy diet decreased expression of inflammatory markers including TNF-α, IL-1β, IL-8, monocyte chemotactic protein 1 and of the proto-oncogenes JUN and FOS in the colorectal mucosa of obese pre-menopausal women 43. In addition, working with participants in a community-based weight loss programme (Slimming World), Kant and colleagues 44 observed lower concentrations of faecal calprotectin (a marker of intestinal inflammation which is increased in colorectal disorders including CRC) only in those participants with a high faecal calprotectin concentration (>50μg g-1) at baseline. Although weight loss in the studies discussed above was relatively modest (typically 5 – 10%), this was sufficient to lower both systemic and tissue-specific markers of inflammation.

Effects of weight loss following bariatric surgery on CRC

A systematic review and meta-analysis of studies reporting on 24, 321 bariatric surgery patients and 80, 866 obese controls found that weight loss induced by bariatric surgery was associated with 27% reduced CRC risk 47. In an English cohort study involving more than 1 million obese participants, bariatric surgery did not alter CRC risk but, in this study, the number of participants who underwent bariatric surgery and the number of CRC cases were small (3.9% of participants underwent bariatric surgery and only 0.1% of the surgery group developed CRC) 48. Similarly, investigations of effects of surgically-induced weight loss on biomarkers of CRC risk have yielded conflicting results. In our recent study, at six months post-bariatric surgery (mean 29kg weight loss), markers of systemic and colorectal mucosal inflammation were reduced, glucose homeostasis was improved and crypt cell proliferation was reduced 49. In contrast, an earlier study found that after bariatric surgery which lowered BMI by 12.6 units, there was increased expression of the pro-inflammatory genes COX-1 and COX-2, decreased apoptosis and increased mitosis in the mucosal crypts 50. In addition, this increased crypt cell proliferation and greater expression of pro-tumourigenic cytokines persisted until at least 3 years post-surgery in these obese patients who underwent Roux-en-Y gastric bypass (RYGB; one of the most common types of bariatric surgery) 51. Differential effects of weight loss following bariatric surgery on CRC-related biomarkers may be due to subtle differences in the nature of the surgical procedures used 5, 49. For example, we hypothesised that the apparently detrimental effects of the specific type of bariatric surgery reported by the Leeds group 50, 51, may be due to greater small bowel malabsorption and, consequently, exposure of the large bowel mucosa to luminal agents such as secondary bile acids that can damage the colorectal mucosa and are associated with increased CRC risk 49. The most likely reason for lack of evidence for effects of weight loss on CRC risk is the short duration of most relevant studies. In addition, such weight loss studies tend to have relatively low sample size, the amount of weight loss is modest and weight loss is not usually sustained in the long term. The most convincing evidence is likely to come from long-term follow-up of those who have undergone bariatric surgery because this produces substantial and sustained weight loss.

Mitochondrial structure and function

Mitochondria are eukaryotic organelles residing in the cytosol that are involved in numerous metabolic pathways including intracellular calcium signalling, iron-sulfur cluster biogenesis, apoptosis and maintenance of membrane potential and with their primary function being adenosine triphosphate (ATP) production via oxidative phosphorylation 52, 53.

Every mitochondrion contains multiple copies of a double-stranded closed circular mitochondrial DNA genome (mtDNA) which are present within the mitochondrial matrix and which are maternally inherited 54. The mtDNA consists of 16,569 base pairs forming an inner light ‘L’ (cytosine rich) and an outer heavy ‘H’ (guanine rich) strand encoding a total of 37 genes 54 which include 22 tRNAs, 13 proteins of the respiratory chain and 2 rRNAs specific to the mitochondria which are required for mtDNA gene translation 55. The mtDNA is wrapped together with proteins into mitochondrial nucleoids and every nucleoid comprises one or two mtDNA molecules 54. This packaging of mtDNA into DNA-protein assemblies (nucleoids) provides an efficient means of ensuring that the mitochondrial genetic material is distributed throughout the mitochondrion and for coordinating mtDNA involvement in cellular metabolism 56. There are five mitochondrial respiratory chain complexes 57 and, in humans, mtDNA encodes the following structural subunits of the mitochondrial respiratory chain: NADH dehydrogenase 1 (MTND1) - MTND6 and MTND4L (complex I), cytochrome b (MTCYB) (complex III), cytochrome c oxidase I (MTCO1) - MTCO3 (complex IV), ATP synthase 6 (MTATP6) and MTATP8 (complex V) 58. The mitochondrial genome also harbours the non-coding D-loop, which contains the promoters for ‘H’ and ‘L’ strand transcription 59. The majority of mitochondrial polypeptides required for the structure and function of the mitochondria are transcribed from nuclear genes and translated in the cytosol prior their transport across the mitochondrial membrane 60. Hence, mitochondrial function depends on both of these genetic systems 60.

Energy metabolism in the mitochondrion and links with mtDNA damage

Since each cell contains multiple mtDNA copies, mutations can affect either all mtDNA molecules (homoplasmy) or only a proportion (heteroplasmy) of the mtDNA in a given cell 60. The level of heteroplasmy can vary from 1% to 99% between cells in the same organ or tissue, across various organs and tissues in the same individual and between people in the same family 61. Mitochondrial DNA mutations include single, large-scale deletions (these are rarely inherited and never homoplasmic), point mutations (these are usually maternally inherited) and acquired somatic mutations and are predominantly due to replication errors and ageing 62. However it has also been shown that they can be generated because of environmental exposures such as bacteria and viruses 63 ultraviolet light 64 and tobacco 65, 66) 53. A homoplasmic pathogenic mtDNA point mutation usually results in a relatively mild biochemical defect often affecting only one tissue or organ although exceptions have been reported 62. In contrast, a heteroplasmic mutation may affect multiple organs and the level of heteroplasmy correlates with the extent of organ involvement and degree of severity of the clinical phenotype (with the biochemical defect usually being severe in affected tissues) 62. The proportion of heteroplasmic mtDNA mutations has to surpass a critical threshold level, typically 60-80%, before the biochemical defect can be detected 67, 68.

Glycolysis and β-oxidation of fatty acids each take place within the cytoplasm but most of the generation of ATP from catabolism of dietary carbohydrates and fats takes place when the common intermediate acetyl CoA enters the mitochondrion and undergoes the citric acid cycle and oxidative phosphorylation. Reactive oxygen species (ROS) are produced as a by-product of reactions involving the electron transport chain, with complex I and complex III being the major sites of ROS production 69, 70. ROS react with all the macromolecules in the cell including lipids, proteins and nucleic acids and these reactions can lead to reversible or irreversible oxidative modifications of these macromolecules and, subsequently, to cell and organ dysfunction 70. In addition, ROS production as a result of other dietary and environmental exposures (e.g. alcohol and tobacco use) can cause the development of mtDNA adducts as well as adducts in the nuclear genome via covalent binding of polycyclic aromatic compounds to the DNA. Since DNA repair mechanisms are much less effective in the mitochondrion than in the nuclear genome 71, ROS may have more adverse effects on the mitochondrial genome and may drive disease development 67, 72, 73.

Mitochondria and CRC

During malignancy a shift to glycolysis from oxidative metabolism, known as the ‘Warburg effect’, occurs 74. A recent review argues that the functions of the Warburg Effect for malignancy and tumour cell proliferation remain unknown and evidence on the role of the Warburg Effect in cancer is equivocal 75. Mouse studies have shown mtDNA mutations in tumour and metastatic tissue. Eukaryotic cells containing the nucleus from one species and the cytoplasm from both the parental species are called cybrids 76. Cybrids with or without a homoplasmic pathogenic point mutation at nucleotide position 8,993 or 9,176 in the MTATP6 gene were transplanted into mice 76. Mutations in MTATP6 conferred an advantage during cancer development 76. A later mouse study also using cybrid technology showed an acquired metastatic potential after mtDNA mutations in the gene encoding NADH were transferred 77. Somatic mtDNA mutations occur frequently in human CRC and these may contribute to oncogenesis or metastatic spread 78, 79. We observed that older people have higher frequencies of somatic mutations in the mitochondrial genome however it is unknown whether this increased mitochondrial mutation load may contribute to the age-related CRC risk 80. When present at high levels, such mutations compromise mtDNA encoded respiratory chain subunits and cytochrome c oxidase activity which causes mitochondrial dysfunction and may be a biomarker of damage 81.

Effects of obesity on mitochondrial function

There is evidence from model systems as well as from direct experimentation in humans that obesity, or over-feeding, leads to mitochondrial dysfunction.

In vitro studies

A few studies have investigated the effects of overfeeding and/ or obesity on mitochondrial structure and function in vitro. For example, treating differentiated 3T3-L1 adipocytes for 48h with high glucose, high free fatty acids (FFAs), or high glucose plus high FFAs resulted in abnormal mitochondrial size, morphology and biogenesis 70. These treatments led to loss of mitochondrial membrane potential, reduced intra-mitochondrial calcium concentration, lower concentrations of mitofusion protein Mfn1 and increased mitofission protein Drp1 70. In addition, the high glucose and high glucose plus high FFAs treatments downregulated expression of NRF1, PGC-1α and mtTFA at the mRNA level and reduced PGC-1β concentration, all of which are important factors in mitochondrial biogenesis 70. Such treatments attempt to mimic the causes (or consequences) of obesity and demonstrate reduced mitochondrial size, morphology and biogenesis.

Studies in animal models

To date, the effects of over-feeding and/ or obesity on mitochondrial structure and function appear to have been little studied in non-mammalian animal models. However, feeding a high sucrose diet to Drosophila induced obesity and caused mitochondrial dysfunction in the ovary 82. This was observed as increased ovarian mtDNA copy number and reduced expression of key mitochondrial regulators including cytochrome c oxidase I, mtTFB1, Parkin and Drosophila homologs of PGC-1α and NRF-2α 82.

A high fat diet (21 days) led to reduced expression of PGC-1α and PCG-1β mRNA, reduced PGC-1α and cytochrome c protein concentrations and downregulation of genes encoding oxidative phosphorylation proteins including complex I-IV in mouse muscle 83. Later studies of high fat feeding also observed mitochondrial dysfunction in skeletal muscle 84, 85 and impaired expression of genes encoding for mitochondrial biogenesis in the rat liver 86. Diet-induced obesity led to reduced mitochondrial mass and function, increased mitochondrial fission rates in rat liver and skeletal muscle, as well as decreased expression of the OPA1 gene and decreased Mfn2 expression which may contribute to mitochondrial dysfunction during obesity 87. Significantly lower eNOS mRNA and protein concentrations were found in white adipose tissue of obese mice, obese Zucker rats and high fat diet induced mice, and in brown adipose tissue of obese mice and obese zucker rats when compared with controls 88. This downregulation of eNOS was accompanied by lower mtDNA content, and reduced mitochondrial proteins involved in cell respiration including COX IV and cytochrome c, and regulators of mitochondrial biogenesis, including PGC-1α, NRF-1 and Tfam in white and brown adipose tissue of obese rodents 88. TNF-α downregulates eNOS and it was suggested that this affects mitochondrial biogenesis 88. A high fat diet also led to reduced complex IV, cytochrome c, HSP60, CORE I, PGC-1α and mtDNA copy number in adipose tissue mitochondria in male rats 89. There is strong evidence that feeding a high fat diet results in reduced mitochondrial function and biogenesis in multiple organs and tissues in rodents evidenced by reduced mtDNA content, PGC-1α concentrations, and expression of cell respiration proteins namely cytochrome c and complex IV.

Obesity causes metabolic disturbances such as insulin resistance and subcellular low-grade inflammation and results in increased oxidative stress and mitochondrial dysfunction in mice suffering from cardiomyopathy 90, 91. In a comparison of the expression of mitochondrial proteins in liver, muscle and adipocytes of normal, obese and diabetic mice, only diabetic mice revealed low concentrations of ATP synthase α and β, complex II and complex III in adipocytes. Additionally, abnormal mitochondrial morphology, reduced mtDNA content, β-oxidation and respiration rates were seen in obese and diabetic mouse adipocytes suggesting an important mitochondrial dysfunction 92. Skeletal muscle of obese mice showed impaired mitochondrial dynamic behaviour via increased fission (increased Fis1 and Drp1 protein concentrations) and reduced fusion (reduced Mfn1 and Mfn2 protein concentrations), reduced mitochondrial respiratory capacity and low ATP content 93.

Effects of over-feeding and of obesity on mitochondrial structure and function in humans

In addition to evidence from in vitro and animal model studies, human studies have demonstrated mitochondrial defects in obesity or when feeding a high fat diet. These studies are summarised in Table 1 and are discussed in more detail below.

Table 1. Effects of obesity on mitochondrial structure and function in humans.

Study Tissue Investigation Key Findings
125 Adipocytes Obesity Reduced PGC-1α concentration
83 Male vastus lateralis and gastrocnemius muscle High fat diet No changes in mtDNA content, TFAM, or NRF1
Reduced concentrations of PGC-1α mRNA, lower activity of cytochrome C oxidase and Citrate synthase
95 Adipocytes Obesity Reduced mtDNA content, oxygen consumption and citrate synthase activity
96 Subcutaneous adipocytes Obesity Reduced mtDNA content, 96 out of 130 CpG sites of mitochondria related transcripts and upstream regulators were hypermethylated, reduced mtDNA-encoded transcripts (12S rRNA, 16S rRNA, COX1, ND5, CYTB) and OXPHOS subunit proteins (complex III-IV)
98 Adipose derived stromal stem cells Obesity Altered DNA methylation: TBX15 was one of the most differentially hypomethylated genes
97 Skeletal muscle Obesity Increased expression of proteins of the TCA cycle and complex II and, decreased expression of proteins forming ATP synthase and complexes I and III

Short-term (3-days) over-feeding with a high fat diet in healthy men resulted in reduced expression of PGC-1α and PCG-1β mRNA, reduced PGC-1α and cytochrome c protein concentrations and downregulation of genes encoding oxidative phosphorylation proteins including complex I-IV in vastus lateralis and gastrocnemius muscle 83. Given the short duration of the intervention, it is not possible to determine whether the observed effects on biomarkers of mitochondrial function are due to changes in adiposity, as distinct from changes in macronutrient intake. Other studies showed that excess nutrient intake may lead to reduced mitochondrial size and number and to reduced oxidative phosphorylation in ectopic brown adipose tissue 94.

Obese individuals showed reduced expression of genes encoding oxidative phosphorylation proteins and reduced oxygen consumption, indicative of a reduction in mitochondrial function 94. Yin and colleagues 95 observed reduced mitochondrial oxidative activity in adipocytes of obese individuals, which may be due to overall adiposity instead of adipocyte hypertrophy. Another study revealed that subcutaneous adipose tissue of obese twins had lower mtDNA content, that 96 out of 130 CpG sites of mitochondria related transcripts and upstream regulators were hypermethylated and reduced mtDNA-encoded transcripts (12S rRNA, 16S rRNA, COX1, ND5, CYTB) and OXPHOS subunit proteins (complex III-V) 96. More recently, Kras 97 found that obesity resulted in 73 and 41 differentially expressed proteins in subsarcolemmal and intermyofibrillar mitochondria respectively in skeletal muscle of 17 obese individuals. Kras 97 observed that proteins making the TCA cycle and complex II were increased, whereas proteins forming ATP synthase and complex I and III were decreased in intermyofibrillar mitochondria of the obese. In obese compared with lean people, mitochondrial network, shape, and number differed in adipose derived stromal stem cells 98. In addition, TBX15 (a negative regulator of mitochondrial mass) was hypomethylated and TBX15 protein concentration was higher in cells from the obese individuals 98.

In summary, there is strong and consistent evidence that over-feeding and/ or obesity result in mitochondrial dysfunction in model systems as well as in humans. Downregulated PGC-1α has been reported consistently in in vitro, animal model and human studies. Reduced mitochondrial content and reduced expression of complex IV and cytochrome c are prominent in animal and human studies, whereas effects on other outcomes such as mitochondrial protein and enzyme concentrations, and on β-oxidation are less consistent.

The potential mechanisms underlying the effects of obesity on mitochondrial dysfunction

Evidence for potential mechanisms underlying the effects of obesity on mitochondrial dysfunction comes largely from in vitro and animal studies with much more limited data from human studies. In addition, this mechanistic work has been undertaken in several different cell types and tissues, with relatively little research undertaken in colonocytes.

A recent review summarised evidence showing that obesity leads to reduced β-oxidation and to mitochondrial dysfunction through excess ROS, oxidative stress and an obesity induced inflammatory response in tissues such as muscle, liver and adipose tissue 99, 100. Rogge 99 found that, during these processes, impaired mitochondria may initiate a vicious cycle of reduced mtDNA content, mitochondrial biogenesis and β-oxidation. Impaired β-oxidation results in increased triacylglycerol synthesis and ectopic deposits of lipids, which can lead to impaired cellular functions and oxidative stress via increased ceramide formation, increased lipid peroxidation by-products, increased nitric oxide synthase concentrations, greater inflammatory cytokine production and excess ROS 99. Excess ROS including superoxide anions, perioxynitrite, hydroxyl radicals and hydrogen peroxide can damage lipids in membranes, proteins (especially OXPHOS enzymes) and nuclear and mitochondrial nucleic acids leading to further cellular damage 99. When fatty acids accumulate in the cytosol, β- and ω-oxidation are activated in peroxisomes and microsomes, respectively 99. Ω-oxidation can damage mitochondria through uncoupling oxidative phosphorylation and disrupting the mitochondrial membrane proton gradient leading to loss of ATP production 99. Furthermore, in obesity, the mitochondria are overloaded with glucose and fatty acids, which increases acetyl-CoA production and, in turn, results in high NADH concentrations produced by the Krebs cycle 100. As a consequence, this increases electron availability to the mitochondrial respiratory chain complexes and increases ROS production which activates transcription factors e.g. NFκB that regulate the inflammatory response 100. The above evidence demonstrated that obesity reduces mitochondrial number, biogenesis and respiratory capacity which results in mitochondrial dysfunction 100.

Effects of weight loss on mitochondrial structure and function

There is evidence from animal models as well as from direct investigations in humans that weight loss and/ or nutrient and energy restriction leads to enhanced mitochondrial integrity, capacity, function and biogenesis.

Studies in animal models

Effects of dietary energy restriction

Animal studies have investigated the effects of dietary energy (caloric) restriction on mitochondrial function. Zid and colleagues 101 revealed that energy restriction in Drosophila potentiated mitochondrial activity by increasing ribosomal loading of genes encoding complex I and IV of the respiratory transport chain. Energy restriction resulted in increased mitochondrial biogenesis, fusion, increased ATP production and increased expression of mRNA of NRF1, TFAM, COX4, Cyt C, MFN1, MFN2, eNOS and PGC-1α in various tissues of male mice 102. Raffaello and Rizzuto 103 demonstrated that many signalling pathways are involved in the expression of genes involved in the stress response; for example genes which reduce mitochondrial ROS production and promote mitochondrial activity and function. Energy restriction downregulated the IGF-1 signalling pathway and induced transcription of the mitochondrial antioxidant gene SOD2 103. Energy restriction can activate the SIRT1 and/ or AMPK signalling pathway(s) which consequently increase PGC-1α concentrations 103. Other studies also found that energy restriction in aged animals activated PCG-1α which, subsequently, activated AMP-activated protein kinase and sirtuins; this improved mitochondrial integrity, biogenesis and reduced mitochondrial derived ROS and damage 104106. Overall, there is consistent evidence that dietary energy restriction improves mitochondrial function via reduced oxidative stress and that this results in activation of PGC-1α and AMP kinase. Evidence suggests that metabolic inputs tightly regulate mitochondrial fusion and fission rates which can improve mitochondrial function 107. Nutrient starvation leads to reduced fission rates, by triggering PKA mediated phosphorylation of Drp1 (a mediator of mitochondrial fission) in mouse embryonic fibroblasts 108. Additionally, nutrient depletion leads to interconnection and elongation of mitochondria through downregulation of Drp1. 108. This increased mitochondrial network, as a result of nutrient depletion, protects against autophagosomal degradation 108. Lee and colleagues 107, 109 found that glucose restriction in mouse skeletal muscle deacetylates and activates Mfn1, a mitofusin implicated in the regulation of mitochondrial morphology and, subsequently leads to mitochondrial fusion which serves as a protection against oxidative stress. McKiernan 110 found no differences in mitochondrial electron transport enzyme abnormalities in skeletal muscle between energy restricted and control rhesus monkeys, but reported large mtDNA deletions (which removed a large proportion of the genome of at least one of the three mitochondrial encoded COX subunits) in fibres with abnormal mitochondrial enzyme activities. In animal models, there is consistent evidence that nutrient and energy depletion improves mitochondrial function through reduced fission and increased mitochondrial fusion rates as a result of downregulated Drp1 and upregulated Mfn1 respectively. However, there is a lack of evidence on the effects of nutrient and energy depletion on mtDNA content, β-oxidation and expression of mitochondrial proteins and enzymes (encoded by the nuclear or mitochondrial genome).

Effects of weight loss on mitochondrial structure and function in humans

In addition to evidence from animal model studies, human studies have demonstrated improved mitochondrial structure and function after energy depletion and weight loss. These studies are summarised in Table 2 and discussed in more detail below.

Table 2. Effects of weight loss on mitochondrial structure and function in obese humans.

Study Tissue Weight-loss Intervention Key Findings
113 Skeletal muscle Bilio-pancreatic diversion Increased Mfn2 expression
111 Muscle Dietary energy restriction with/without increased physical activity Increased expression of PARGC1A, TFAM, eNOS, SIRT1 and PARL and increased mtDNA content
112 Skeletal muscle Dietary energy restriction with/without increased physical activity No change in diet-only group Increased mtDNA and NADH-oxidase activity, improvement in aerobic capacity and mitochondrial content in the diet plus exercise group
114 Vastus lateralis muscle RYGB with exercise intervention or health education Increased OXPHOS proteins, NADH oxidase, citrate synthase, creatine kinase and cardiolipin in the RYGB with exercise intervention
116 Subcutaneous adipose tissue RYGB Improved mitochondrial biogenesis via increased concentrations of PGC-1α, NRF1, Cyt C, Tfam and eNOS; reduced protein carbonylation
117 Subcutaneous adipose tissue Bariatric surgery No effect in normoglycemic women, increased PGC-1α and reduced mitofilin in initially insulin resistant women
115 Vastus lateralis muscle RYGB Increased coupled and uncoupled respiration, oxidative phosphorylation ratio and citrate synthase activity
118 Muscle and adipose tissue RYGB Adipocytes became smaller and richer in mitochondria

The effects of weight loss via diet and/ or exercise

In 36 young overweight subjects, induction of negative energy balance by 25% (though dietary energy restriction, or dietary restriction plus increase in energy expenditure through exercise) resulted in increased expression of genes involved in mitochondrial function (PPARGC1A, TFAM, eNOS, SIRT1, and PARL), and increased mtDNA content but had no effect on mitochondrial enzyme activity (citrate synthase (for TCA cycle), beta-hydroxyacyl-CoA dehydrogenase (for β-oxidation) and cytochrome C oxidase II (for the electron transport chain)) in muscle 111. Improvement in aerobic capacity, mitochondrial content and reduced mitochondrial size in skeletal muscle were observed in a diet plus exercise intervention (mean 8.5kg weight loss achieved) but not in a diet alone weight loss intervention (mean 10.6kg weight loss achieved) 112. The larger effects of the combination of diet and exercise on mitochondria might not be due to weight loss per se but because exercise has independent, and synergistic, effects on mitochondria to those of dietary energy reduction alone 112.

The effects of weight loss following bariatric surgery

Expression of Mfn2, which is an essential mitochondrial fusion protein and contributes to mitochondrial network integrity, was reduced in skeletal muscle of obese individuals. However, 2 years after bilio-pancreatic diversion surgery which caused a 25 kg/m2 unit fall in BMI (resulting in mean 31 kg/m2 BMI). Mfn2 expression was increased significantly suggesting that Mfn2 expression is inversely proportional to body weight 113. A study involving 101 Roux-en-Y gastric bypass (RYGB) patients allocated either to an exercise or health education control intervention, found at 6 months follow-up that a mean 23.6kg weight loss by RYGB in addition to the exercise intervention enhanced mitochondrial respiration in vastus lateralis muscle tissue. Although the RYGB plus health education achieved similar weight loss (mean 22.1kg) to the RYGB plus exercise intervention it did not alter mitochondrial respiration. Neither intervention arm showed a change in OXPHOS content and all patients remained obese (mean 30.4 kg/m2 BMI) at follow-up 114; it is unclear if the effects were due to weight loss per se. Fernstrom 115 reported that at 6 months after RYGB, mean weight loss in 11 obese females was 25.5kg and resulted in increased coupled respiration in vastus lateralis muscle. However, there were no effects on respiratory control index (a quality measure of isolated mitochondria) and uncoupled respiration (oxygen consumption without ADP phosphorylation), and although patients achieved significant weight loss they remained overweight post-operatively with a mean BMI of 29.6 kg/m2. These studies show that sustained and significant weight loss following bariatric surgery results in increased mitochondrial fusion protein Mfn2 and enhanced mitochondrial (coupled) respiration in muscle tissue 113115.

Jahansouz 116 investigated the short-term (7.5 days) effect of RYGB (n=8) and adjustable gastric banding (n=8). Although, at this stage weight loss was small and non-significant, (mean 0.9 kg/m2 unit fall in BMI) expression of PGC-1 α, NRF1, Cyt C, Tfam and eNOS were increased. Expression of these genes is associated with mitochondrial biogenesis, and protein carbonylation, a marker of oxidative stress, which was lower in the adipose tissue. These effects were evident after RYGB but adjustable gastric banding had no effect. Following bariatric surgery a rapid improvement in glycemic control occurs, prior to weight reduction, suggesting that the observed changes in gene expression might be due to metabolic changes linked to bariatric surgery, rather than to weight loss per se. Obese women (n=18) were allocated to a normoglycemic group and to an insulin resistant group before they underwent bariatric surgery. Subsequent investigations in subcutaneous adipose tissue 13 months post-operatively revealed that the normoglycemic group (14.2 kg/m2 unit fall in BMI) showed decreases in mitofilin and PGC-1α concentrations, whereas the insulin resistant group (17.5 kg/m2 unit fall in BMI) had changes in the opposite direction for mitofilin and PGC-1α concentrations 117. This suggests that the effects of surgically induced weight loss on mitochondrial function may depend on initial metabolic status 117. In 19 obese patients, individuals who achieved mean 33% weight loss at one-year post-RYGB had smaller adipocytes which were richer in mitochondria 118. Significant and sustained weight loss following bariatric surgery results in increased number of mitochondria, upregulated gene expression (coding for mitochondrial biogenesis, function and dynamic) and reduced oxidative stress 116119.

To date, the studies investigating the effect of weight loss by bariatric surgery have focussed on effects in muscle and adipose tissue only and more studies in other tissues are warranted. These studies varied in duration of follow-up (7.5 days to 13 months), type of bariatric surgery procedure and weight and BMI loss achieved (11.6kg - 25.5kg and BMI 0.9- 25 kg/m2, respectively) and these differences in study design may explain the lack of consistent results on mitochondrial structure and function. One important limitation of all studies discussed above is that the patients remained overweight and/ or obese post-surgery and there is a lack of evidence of effects of weight loss leading to a normal weight on these mitochondrial outcomes. Finally, physical activity/ exercise seems have additional benefits on mitochondrial outcomes beyond those of weight loss per se, but this is beyond the scope of this paper and will not be discussed here.

There is strong and consistent evidence that weight loss by dietary intervention or bariatric surgery leads to an increase in fusion proteins and PGC-1α concentrations, and a reduction in oxidative stress in both animal and human studies. Expression of genes such as Tfam and eNos were increased after a diet and exercise intervention and RYGB in humans indicating improved mitochondrial capacity. Weight loss increased gene expression of proteins encoding the respiratory transport chain in animals and humans but evidence of effects on enzyme activity is lacking for both animal and human studies. More studies in females have investigated the effects of bariatric surgery and found increased mitochondrial respiration and differential mitochondrial gene expression leading to improved mitochondrial function. We are not aware of studies that have investigated the effect of weight loss on existing mitochondrial genomic damage. The evidence on increased mtDNA content after weight loss is limited in both animal and human. Overall, there is some evidence that weight loss results in improvements of mitochondrial structure and function but more studies are needed to confirm the limited findings to date.

The potential mechanisms underlying the effects of weight loss on mitochondrial function

Energy and nutrient restriction, either via fasting, dietary energy restriction or increased physical activity, increases cAMP concentration and AMP/ATP ratio which triggers the PKA/CREB, SIRT1 and AMPK signalling pathways and, in turn, activates PGC-1α 120, 121. PGC-1α is the key regulator of mitochondrial biogenesis which activates downstream targets including Tfam, Nrf1 and Nrf2, resulting in upregulation of mitochondrial activity and biogenesis 121.

Effect of weight loss on mitochondrial structure and function in the human colon

Animal and human studies provide evidence of causal links between increased adiposity and mitochondrial dysfunction. In addition, weight loss in those who are overweight or obese results in enhanced mitochondrial structure and function in various tissues, particularly skeletal muscle and adipose tissue. However, few studies have investigated the effects of obesity on mitochondrial function in the colon; all of these have been in vitro or in animal models and we are unaware of any published evidence on the effects of obesity or of weight loss on mitochondrial structure and function in the human colon.

For example, in a rat model of diet-induced obesity, two groups, rats from the lowest and highest quartile of obese body weight, were selected. Principal component analysis showed that increased adiposity in the group with the highest body weight was associated with 27 out of the 69 colon mitochondrial associated proteins in colon tissue. Over half of these proteins were downregulated suggesting reduced ATP production, protein transport and folding and, increased oxidative stress during obesity; however, these changes in mitochondrial associated proteins were not correlated with their corresponding gene expression in colon in response to increased adiposity 122. To verify if obesity contributes to increased CRC risk by causing mitochondrial dysfunction and reducing OXPHOS gene expression, Nimri 123 exposed MC38 and CT26 mouse colon cancer cells to conditioned media obtained from adipose tissue of mice that were fed a high fat diet. Nimri 123 found a reduced oxygen consumption rate and a downregulation of mitochondrial gene expression mediated by the JNK/ STAT-3-signalling pathway. In human HCT116 colon cancer cells, those exposed to media from cultured human visceral adipose tissue fragments of obese individuals had reduced expression of mitochondrial respiratory chain complexes e.g. COX1, COX2, COX4 and SDHs compared with those exposed to media from non-obese individuals. This supports the notion that media from obese individuals may induce mitochondrial dysfunction (reduced mitochondrial respiration and function) in HCT116 cells 124. These findings suggest that mitochondria may play a role in obesity-induced colorectal tumorigenesis but more evidence is needed to confirm this hypothesis.

We are investigating the effect of obesity and of weight loss following bariatric surgery on mitochondrial function in the human colorectal mucosa. Using immunofluorescence, we have quantified expression of oxidative phosphorylation proteins, namely complex I and IV, in colonocytes from obese individuals before and 6 months after bariatric surgery when they had lost 27kg body mass in comparison with matched non-obese controls 49.

Conclusion

CRC risk is increased by obesity and by its lifestyle determinants including physical inactivity, sedentary behaviour and poor diet. Mutations accumulate during ageing leading to mitochondrial dysfunction, however it is unknown whether these are more prevalent in obese individuals. There is limited evidence suggesting that weight loss may reduce CRC risk and enhance mitochondrial activity, integrity and biogenesis. Furthermore, most of the evidence is derived from animal studies and from other tissues such as adipose tissue or skeletal muscle. In conclusion, the role of obesity and weight loss (including surgically-induced weight loss) on mitochondrial structure and function in the human colon is currently unknown and warrants further investigation.

Acknowledgments

Not applicable.

Financial support

This work was supported by the Newcastle University Centre for Ageing and Vitality (supported by the Biotechnology and Biological Sciences Research Council and Medical Research Council L016354), The Wellcome Trust (203105/Z/16/Z and 204709/Z/16/Z), UK NIHR Biomedical Research Centre for Ageing and Age-related disease award to the Newcastle upon Tyne Hospitals NHS Foundation Trust and by Northumbria Healthcare NHS Foundation Trust.

Footnotes

Conflict of Interest

None.

Authorship

The concept for this manuscript was developed by SPB and JCM, SPB drafted the manuscript, JCM edited the manuscript and the final version was agreed by all authors.

References

  • 1.Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer Journal international du cancer. 2015 Mar 01;136(5):E359–86. doi: 10.1002/ijc.29210. [DOI] [PubMed] [Google Scholar]
  • 2.Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2016 Jan 27; doi: 10.1136/gutjnl-2015-310912. [DOI] [PubMed] [Google Scholar]
  • 3.Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2010 Jan;11(1):19–30. doi: 10.1111/j.1467-789X.2009.00613.x. [DOI] [PubMed] [Google Scholar]
  • 4.Omata F, Deshpande GA, Ohde S, et al. The association between obesity and colorectal adenoma: systematic review and meta-analysis. Scandinavian journal of gastroenterology. 2013 Feb;48(2):136–46. doi: 10.3109/00365521.2012.737364. [DOI] [PubMed] [Google Scholar]
  • 5.Mathers JC. Obesity and bowel cancer: from molecular mechanisms to interventions. Nutrition research (New York, NY) 2018 Sep 1; doi: 10.1016/j.nutres.2018.08.004. [DOI] [PubMed] [Google Scholar]
  • 6.Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PloS one. 2013;8(1):e53916. doi: 10.1371/journal.pone.0053916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Keum N, Lee DH, Kim R, et al. Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studies. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Jun;26(6):1101–9. doi: 10.1093/annonc/mdu563. [DOI] [PubMed] [Google Scholar]
  • 8.Mundade R, Imperiale TF, Prabhu L, et al. Genetic pathways, prevention, and treatment of sporadic colorectal cancer. Oncoscience. 2014;1(6):400–6. doi: 10.18632/oncoscience.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fearon ER. Molecular genetics of colorectal cancer. Annual review of pathology. 2011;6:479–507. doi: 10.1146/annurev-pathol-011110-130235. [DOI] [PubMed] [Google Scholar]
  • 10.Humphries A, Wright NA. Colonic crypt organization and tumorigenesis. Nat Rev Cancer. 2008 Jun;8(6):415–24. doi: 10.1038/nrc2392. [DOI] [PubMed] [Google Scholar]
  • 11.Lao VV, Grady WM. Epigenetics and colorectal cancer. Nature reviews Gastroenterology & hepatology. 2011 Oct 18;8(12):686–700. doi: 10.1038/nrgastro.2011.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. The New England journal of medicine. 1988 Sep 01;319(9):525–32. doi: 10.1056/NEJM198809013190901. [DOI] [PubMed] [Google Scholar]
  • 13.Vazquez A, Bond EE, Levine AJ, et al. The genetics of the p53 pathway, apoptosis and cancer therapy. Nature reviews Drug discovery. 2008 Dec;7(12):979–87. doi: 10.1038/nrd2656. [DOI] [PubMed] [Google Scholar]
  • 14.William MG, Sanford DM. 28 TGF-β Signaling Pathway and Tumor Suppression. 2008 [Google Scholar]
  • 15.Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4;144(5):646–74. doi: 10.1016/j.cell.2011.02.013. [DOI] [PubMed] [Google Scholar]
  • 16.Grady WM, Rajput A, Myeroff L, et al. Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res. 1998 Jul 15;58(14):3101–4. [PubMed] [Google Scholar]
  • 17.Bellam N, Pasche B. Tgf-beta signaling alterations and colon cancer. Cancer treatment and research. 2010;155:85–103. doi: 10.1007/978-1-4419-6033-7_5. [DOI] [PubMed] [Google Scholar]
  • 18.Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science (New York, NY) 2006 Oct 13;314(5797):268–74. doi: 10.1126/science.1133427. [DOI] [PubMed] [Google Scholar]
  • 19.Eppert K, Scherer SW, Ozcelik H, et al. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 1996 Aug 23;86(4):543–52. doi: 10.1016/s0092-8674(00)80128-2. [DOI] [PubMed] [Google Scholar]
  • 20.Takaku K, Oshima M, Miyoshi H, et al. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell. 1998 Mar 06;92(5):645–56. doi: 10.1016/s0092-8674(00)81132-0. [DOI] [PubMed] [Google Scholar]
  • 21.Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science (New York, NY) 2007 Nov 16;318(5853):1108–13. doi: 10.1126/science.1145720. [DOI] [PubMed] [Google Scholar]
  • 22.Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008 Oct;135(4):1079–99. doi: 10.1053/j.gastro.2008.07.076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Colussi D, Brandi G, Bazzoli F, et al. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. International journal of molecular sciences. 2013 Aug 7;14(8):16365–85. doi: 10.3390/ijms140816365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: 2007. [Google Scholar]
  • 25.World Cancer Research Fund. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. 2018 [Google Scholar]
  • 26.Edwards RA, Witherspoon M, Wang K, et al. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. Cancer Res. 2009 Aug 15;69(16):6423–9. doi: 10.1158/0008-5472.CAN-09-1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kiraly O, Gong G, Olipitz W, et al. Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo. PLoS genetics. 2015 Feb;11(2):e1004901. doi: 10.1371/journal.pgen.1004901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Tuo D, Christopher JL, Stephen B, et al. Obesity, Inflammation, and Cancer. Annual Review of Pathology: Mechanisms of Disease. 2016;11(1):421–49. doi: 10.1146/annurev-pathol-012615-044359. [DOI] [PubMed] [Google Scholar]
  • 29.Wei EK, Ma J, Pollak MN, et al. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005 Apr;14(4):850–5. doi: 10.1158/1055-9965.EPI-04-0661. [DOI] [PubMed] [Google Scholar]
  • 30.Gunter MJ, Stolzenberg-Solomon R, Cross AJ, et al. A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res. 2006 Feb 15;66(4):2483–7. doi: 10.1158/0008-5472.CAN-05-3631. [DOI] [PubMed] [Google Scholar]
  • 31.Otani T, Iwasaki M, Sasazuki S, et al. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006 Apr;15(4):690–5. doi: 10.1158/1055-9965.EPI-05-0708. [DOI] [PubMed] [Google Scholar]
  • 32.Erlinger TP, Platz EA, Rifai N, et al. C-reactive protein and the risk of incident colorectal cancer. Jama. 2004 Feb 04;291(5):585–90. doi: 10.1001/jama.291.5.585. [DOI] [PubMed] [Google Scholar]
  • 33.Poullis A, Foster R, Shetty A, et al. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2004 Feb;13(2):279–84. doi: 10.1158/1055-9965.epi-03-0160. [DOI] [PubMed] [Google Scholar]
  • 34.John BJ, Irukulla S, Abulafi AM, et al. Systematic review: adipose tissue, obesity and gastrointestinal diseases. Alimentary pharmacology & therapeutics. 2006 Jun 01;23(11):1511–23. doi: 10.1111/j.1365-2036.2006.02915.x. [DOI] [PubMed] [Google Scholar]
  • 35.Karin M, Cao Y, Greten FR, et al. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002 Apr;2(4):301–10. doi: 10.1038/nrc780. [DOI] [PubMed] [Google Scholar]
  • 36.Steinbach G, Heymsfield S, Olansen NE, et al. Effect of Caloric Restriction on Colonic Proliferation in Obese Persons: Implications for Colon Cancer Prevention. Cancer Research. 1994;54(5):1194–7. [PubMed] [Google Scholar]
  • 37.Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010 Jan 22;140(2):197–208. doi: 10.1016/j.cell.2009.12.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ma C, Avenell A, Bolland M, et al. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ. 2017;359 doi: 10.1136/bmj.j4849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Karahalios A, English DR, Simpson JA. Weight change and risk of colorectal cancer: a systematic review and meta-analysis. Am J Epidemiol. 2015 Jun 1;181(11):832–45. doi: 10.1093/aje/kwu357. [DOI] [PubMed] [Google Scholar]
  • 40.Beeken RJ, Croker H, Heinrich M, et al. The Impact of Diet-Induced Weight Loss on Biomarkers for Colorectal Cancer: An Exploratory Study (INTERCEPT) Obesity (Silver Spring, Md) 2017 Nov;25(Suppl 2):S95–101. doi: 10.1002/oby.21984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Nicklas BJ, Ambrosius W, Messier SP, et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr. 2004 Apr;79(4):544–51. doi: 10.1093/ajcn/79.4.544. [DOI] [PubMed] [Google Scholar]
  • 42.Lakhdar N, Denguezli M, Zaouali M, et al. Diet and diet combined with chronic aerobic exercise decreases body fat mass and alters plasma and adipose tissue inflammatory markers in obese women. Inflammation. 2013 Dec;36(6):1239–47. doi: 10.1007/s10753-013-9661-8. [DOI] [PubMed] [Google Scholar]
  • 43.Pendyala S, Neff LM, Suárez-Fariñas M, et al. Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. The American Journal of Clinical Nutrition. 2011 Feb 1;93(2):234–42. doi: 10.3945/ajcn.110.002683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Kant P, Fazakerley R, Hull MA. Faecal calprotectin levels before and after weight loss in obese and overweight subjects. International journal of obesity (2005) 2013 Feb;37(2):317–9. doi: 10.1038/ijo.2012.38. [DOI] [PubMed] [Google Scholar]
  • 45.Schauer DP, Feigelson HS, Koebnick C, et al. Association Between Weight Loss and the Risk of Cancer after Bariatric Surgery. Obesity (Silver Spring, Md) 2017 Nov;25(Suppl 2):52–7. doi: 10.1002/oby.22002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort. Annals of surgery. 2017 Sep 21; doi: 10.1097/SLA.0000000000002525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Afshar S, Kelly SB, Seymour K, et al. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obesity surgery. 2014 Oct;24(10):1793–9. doi: 10.1007/s11695-014-1359-y. [DOI] [PubMed] [Google Scholar]
  • 48.Aravani A, Downing A, Thomas JD, et al. Obesity surgery and risk of colorectal and other obesity-related cancers: An English population-based cohort study. Cancer epidemiology. 2018 Apr;53:99–104. doi: 10.1016/j.canep.2018.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Afshar S, Malcomson F, Kelly SB, et al. Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery. Obesity surgery. 2018 Apr;28(4):945–54. doi: 10.1007/s11695-017-2953-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Sainsbury A, Goodlad RA, Perry SL, et al. Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008 Jun;17(6):1401–10. doi: 10.1158/1055-9965.EPI-07-2874. [DOI] [PubMed] [Google Scholar]
  • 51.Kant P, Sainsbury A, Reed KR, et al. Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB. Gut. 2011 Jul;60(7):893–901. doi: 10.1136/gut.2010.230755. [DOI] [PubMed] [Google Scholar]
  • 52.Fernandez-Silva P, Enriquez JA, Montoya J. Replication and transcription of mammalian mitochondrial DNA. Experimental physiology. 2003 Jan;88(1):41–56. doi: 10.1113/eph8802514. [DOI] [PubMed] [Google Scholar]
  • 53.Stewart JB, Chinnery PF. The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nature reviews Genetics. 2015 Sep;16(9):530–42. doi: 10.1038/nrg3966. [DOI] [PubMed] [Google Scholar]
  • 54.Case JT, Wallace DC. Maternal inheritance of mitochondrial DNA polymorphisms in cultured human fibroblasts. Somatic cell genetics. 1981 Jan;7(1):103–8. doi: 10.1007/BF01544751. [DOI] [PubMed] [Google Scholar]
  • 55.Carling PJ, Cree LM, Chinnery PF. The implications of mitochondrial DNA copy number regulation during embryogenesis. Mitochondrion. 2011 Sep;11(5):686–92. doi: 10.1016/j.mito.2011.05.004. [DOI] [PubMed] [Google Scholar]
  • 56.Gilkerson R, Bravo L, Garcia I, et al. The mitochondrial nucleoid: integrating mitochondrial DNA into cellular homeostasis. Cold Spring Harbor perspectives in biology. 2013 May 1;5(5):a011080. doi: 10.1101/cshperspect.a011080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Sousa JS, D'Imprima E, Vonck J. Mitochondrial Respiratory Chain Complexes. Sub-cellular biochemistry. 2018;87:167–227. doi: 10.1007/978-981-10-7757-9_7. [DOI] [PubMed] [Google Scholar]
  • 58.Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457. doi: 10.1038/290457a0. 04/09/online. [DOI] [PubMed] [Google Scholar]
  • 59.Shadel GS, Clayton DA. Mitochondrial transcription initiation. Variation and conservation. Journal of Biological Chemistry. 1993 Aug 5;268(22):16083–6. 1993. [PubMed] [Google Scholar]
  • 60.Larsson NG, Clayton DA. Molecular genetic aspects of human mitochondrial disorders. Annual review of genetics. 1995;29:151–78. doi: 10.1146/annurev.ge.29.120195.001055. [DOI] [PubMed] [Google Scholar]
  • 61.Johns DR. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. The New England journal of medicine. 1995 Sep 7;333(10):638–44. doi: 10.1056/NEJM199509073331007. [DOI] [PubMed] [Google Scholar]
  • 62.Gorman GS, Chinnery PF, DiMauro S, et al. Mitochondrial diseases. Nature reviews Disease primers. 2016 Oct 20;2 doi: 10.1038/nrdp.2016.80. 16080. [DOI] [PubMed] [Google Scholar]
  • 63.Machado AM, Figueiredo C, Seruca R, et al. Helicobacter pylori infection generates genetic instability in gastric cells. Biochimica et biophysica acta. 2010 Aug;1806(1):58–65. doi: 10.1016/j.bbcan.2010.01.007. [DOI] [PubMed] [Google Scholar]
  • 64.Birch-Machin MA, Swalwell H. How mitochondria record the effects of UV exposure and oxidative stress using human skin as a model tissue. Mutagenesis. 2010 Mar;25(2):101–7. doi: 10.1093/mutage/gep061. [DOI] [PubMed] [Google Scholar]
  • 65.Prior SL, Griffiths AP, Baxter JM, et al. Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis. 2006 May;27(5):945–50. doi: 10.1093/carcin/bgi326. [DOI] [PubMed] [Google Scholar]
  • 66.Tan D, Goerlitz DS, Dumitrescu RG, et al. Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells. Carcinogenesis. 2008;29(6):1170–7. doi: 10.1093/carcin/bgn034. 02/14 10/11/received 01/22/revised 01/28/accepted. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science (New York, NY) 1989 Oct 27;246(4929):500–3. doi: 10.1126/science.2814477. [DOI] [PubMed] [Google Scholar]
  • 68.Boulet L, Karpati G, Shoubridge EA. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF) American journal of human genetics. 1992 Dec;51(6):1187–200. [PMC free article] [PubMed] [Google Scholar]
  • 69.Chen Q, Vazquez EJ, Moghaddas S, et al. Production of reactive oxygen species by mitochondria: central role of complex III. The Journal of biological chemistry. 2003 Sep 19;278(38):36027–31. doi: 10.1074/jbc.M304854200. [DOI] [PubMed] [Google Scholar]
  • 70.Gao CL, Zhu C, Zhao YP, et al. Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes. Molecular and cellular endocrinology. 2010 May 14;320(1–2):25–33. doi: 10.1016/j.mce.2010.01.039. [DOI] [PubMed] [Google Scholar]
  • 71.Zinovkina LA. Mechanisms of Mitochondrial DNA Repair in Mammals. Biochemistry Biokhimiia. 2018 Mar;83(3):233–49. doi: 10.1134/S0006297918030045. [DOI] [PubMed] [Google Scholar]
  • 72.Allen JA, Coombs MM. Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature. 1980 Sep 18;287(5779):244–5. doi: 10.1038/287244a0. [DOI] [PubMed] [Google Scholar]
  • 73.Cakir Y, Yang Z, Knight CA, et al. Effect of alcohol and tobacco smoke on mtDNA damage and atherogenesis. Free radical biology & medicine. 2007 Nov 01;43(9):1279–88. doi: 10.1016/j.freeradbiomed.2007.07.015. [DOI] [PubMed] [Google Scholar]
  • 74.Warburg O. On respiratory impairment in cancer cells. Science (New York, NY) 1956 Aug 10;124(3215):269–70. [PubMed] [Google Scholar]
  • 75.Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends in biochemical sciences. 2016 Mar;41(3):211–8. doi: 10.1016/j.tibs.2015.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Shidara Y, Yamagata K, Kanamori T, et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 2005 Mar 1;65(5):1655–63. doi: 10.1158/0008-5472.CAN-04-2012. [DOI] [PubMed] [Google Scholar]
  • 77.Ishikawa K, Takenaga K, Akimoto M, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science (New York, NY) 2008 May 2;320(5876):661–4. doi: 10.1126/science.1156906. [DOI] [PubMed] [Google Scholar]
  • 78.Polyak K, Li Y, Zhu H, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nature genetics. 1998 Nov;20(3):291–3. doi: 10.1038/3108. [DOI] [PubMed] [Google Scholar]
  • 79.He Y, Wu J, Dressman DC, et al. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature. 2010 Mar 25;464(7288):610–4. doi: 10.1038/nature08802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Greaves LC, Nooteboom M, Elson JL, et al. Clonal expansion of early to mid-life mitochondrial DNA point mutations drives mitochondrial dysfunction during human ageing. PLoS genetics. 2014 Sep;10(9) doi: 10.1371/journal.pgen.1004620. e1004620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Greaves LC, Barron MJ, Plusa S, et al. Defects in multiple complexes of the respiratory chain are present in ageing human colonic crypts. Experimental gerontology. 2010 Aug;45(7–8):573–9. doi: 10.1016/j.exger.2010.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Brookheart RT, Swearingen AR, Collins CA, et al. High-sucrose-induced maternal obesity disrupts ovarian function and decreases fertility in Drosophila melanogaster. Biochimica et biophysica acta. 2017 Mar 24; doi: 10.1016/j.bbadis.2017.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Sparks LM, Xie H, Koza RA, et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes. 2005 Jul;54(7):1926–33. doi: 10.2337/diabetes.54.7.1926. [DOI] [PubMed] [Google Scholar]
  • 84.Stewart LK, Wang Z, Ribnicky D, et al. Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity. Diabetologia. 2009 Mar;52(3):514–23. doi: 10.1007/s00125-008-1252-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Devarshi PP, McNabney SM, Henagan TM. Skeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes. International journal of molecular sciences. 2017 Apr 14;18(4) doi: 10.3390/ijms18040831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Das N, Mandala A, Bhattacharjee S, et al. Dietary fat proportionately enhances oxidative stress and glucose intolerance followed by impaired expression of the genes associated with mitochondrial biogenesis. Food & function. 2017 Apr 19;8(4):1577–86. doi: 10.1039/c6fo01326k. [DOI] [PubMed] [Google Scholar]
  • 87.Putti R, Sica R, Migliaccio V, et al. Diet impact on mitochondrial bioenergetics and dynamics. Frontiers in physiology. 2015;6:109. doi: 10.3389/fphys.2015.00109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Valerio A, Cardile A, Cozzi V, et al. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. The Journal of clinical investigation. 2006 Oct;116(10):2791–8. doi: 10.1172/JCI28570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Sutherland LN, Capozzi LC, Turchinsky NJ, et al. Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: Potential mechanisms and the relationship to glucose intolerance. American Journal of Physiology - Endocrinology and Metabolism. 2008;295(5):E1076–E83. doi: 10.1152/ajpendo.90408.2008. [DOI] [PubMed] [Google Scholar]
  • 90.Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovascular research. 2017 Mar 15;113(4):389–98. doi: 10.1093/cvr/cvx012. [DOI] [PubMed] [Google Scholar]
  • 91.Guo CA, Guo S. Insulin receptor substrate signaling controls cardiac energy metabolism and heart failure. The Journal of endocrinology. 2017 Apr 05; doi: 10.1530/JOE-16-0679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Choo HJ, Kim JH, Kwon OB, et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia. 2006;49(4):784–91. doi: 10.1007/s00125-006-0170-2. [DOI] [PubMed] [Google Scholar]
  • 93.Liu R, Jin P, Yu Liqun, et al. Impaired Mitochondrial Dynamics and Bioenergetics in Diabetic Skeletal Muscle. PloS one. 2014;9(3):e92810. doi: 10.1371/journal.pone.0092810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Bournat JC, Brown CW. Mitochondrial dysfunction in obesity. Current opinion in endocrinology, diabetes, and obesity. 2010 Oct;17(5):446–52. doi: 10.1097/MED.0b013e32833c3026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Yin X, Lanza IR, Swain JM, et al. Adipocyte Mitochondrial Function Is Reduced in Human Obesity Independent of Fat Cell Size. The Journal of clinical endocrinology and metabolism. 2014;99(2):E209–E16. doi: 10.1210/jc.2013-3042. 11/25 08/02/received 11/12/accepted. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Heinonen S, Buzkova J, Muniandy M, et al. Impaired Mitochondrial Biogenesis in Adipose Tissue in Acquired Obesity. Diabetes. 2015 Sep;64(9):3135–45. doi: 10.2337/db14-1937. [DOI] [PubMed] [Google Scholar]
  • 97.Kras KA, Langlais PR, Hoffman N, et al. Obesity modifies the stoichiometry of mitochondrial proteins in a way that is distinct to the subcellular localization of the mitochondria in skeletal muscle. Metabolism. 2018 Dec;89:18–26. doi: 10.1016/j.metabol.2018.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Ejarque M, Ceperuelo-Mallafré V, Serena C, et al. Adipose tissue mitochondrial dysfunction in human obesity is linked to a specific DNA methylation signature in adipose-derived stem cells. International Journal of Obesity. 2018 Sep 27; doi: 10.1038/s41366-018-0219-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Rogge MM. The role of impaired mitochondrial lipid oxidation in obesity. Biological research for nursing. 2009 Apr;10(4):356–73. doi: 10.1177/1099800408329408. [DOI] [PubMed] [Google Scholar]
  • 100.de Mello AH, Costa AB, Engel JDG, et al. Mitochondrial dysfunction in obesity. Life sciences. 2018 Jan 01;192:26–32. doi: 10.1016/j.lfs.2017.11.019. [DOI] [PubMed] [Google Scholar]
  • 101.Zid BM, Rogers AN, Katewa SD, et al. 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila. Cell. 2009 Oct 2;139(1):149–60. doi: 10.1016/j.cell.2009.07.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Nisoli E, Tonello C, Cardile A, et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science (New York, NY) 2005 Oct 14;310(5746):314–7. doi: 10.1126/science.1117728. [DOI] [PubMed] [Google Scholar]
  • 103.Raffaello A, Rizzuto R. Mitochondrial longevity pathways. Biochimica et biophysica acta. 2011 Jan;1813(1):260–8. doi: 10.1016/j.bbamcr.2010.10.007. [DOI] [PubMed] [Google Scholar]
  • 104.Reznick RM, Zong H, Li J, et al. Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell metabolism. 2007 Feb;5(2):151–6. doi: 10.1016/j.cmet.2007.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Burnett C, Valentini S, Cabreiro F, et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature. 2011 Sep 21;477(7365):482–5. doi: 10.1038/nature10296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Martin-Montalvo A, de Cabo R. Mitochondrial metabolic reprogramming induced by calorie restriction. Antioxidants & redox signaling. 2013 Jul 20;19(3):310–20. doi: 10.1089/ars.2012.4866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Wai T, Langer T. Mitochondrial Dynamics and Metabolic Regulation. Trends in Endocrinology & Metabolism. 2016 Feb 01;27(2):105–17. doi: 10.1016/j.tem.2015.12.001. [DOI] [PubMed] [Google Scholar]
  • 108.Rambold AS, Kostelecky B, Elia N, et al. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proceedings of the National Academy of Sciences of the United States of America. 2011 Jun 21;108(25):10190–5. doi: 10.1073/pnas.1107402108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Lee JY, Kapur M, Li M, et al. MFN1 deacetylation activates adaptive mitochondrial fusion and protects metabolically challenged mitochondria. Journal of cell science. 2014 Nov 15;127(Pt 22):4954–63. doi: 10.1242/jcs.157321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.McKiernan SH, Colman RJ, Lopez M, et al. Caloric restriction delays aging-induced cellular phenotypes in rhesus monkey skeletal muscle. Experimental gerontology. 2011;46(1):23–9. doi: 10.1016/j.exger.2010.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Civitarese AE, Carling S, Heilbronn LK, et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS medicine. 2007 Mar;4(3):e76. doi: 10.1371/journal.pmed.0040076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Toledo FG, Menshikova EV, Azuma K, et al. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes. 2008 Apr;57(4):987–94. doi: 10.2337/db07-1429. [DOI] [PubMed] [Google Scholar]
  • 113.Bach D, Naon D, Pich S, et al. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes. 2005 Sep;54(9):2685–93. doi: 10.2337/diabetes.54.9.2685. [DOI] [PubMed] [Google Scholar]
  • 114.Coen PM, Menshikova EV, Distefano G, et al. Exercise and Weight Loss Improve Muscle Mitochondrial Respiration, Lipid Partitioning, and Insulin Sensitivity After Gastric Bypass Surgery. Diabetes. 2015 Nov;64(11):3737–50. doi: 10.2337/db15-0809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Fernstrom M, Bakkman L, Loogna P, et al. Improved Muscle Mitochondrial Capacity Following Gastric Bypass Surgery in Obese Subjects. Obesity surgery. 2016 Jul;26(7):1391–7. doi: 10.1007/s11695-015-1932-z. [DOI] [PubMed] [Google Scholar]
  • 116.Jahansouz C, Serrot FJ, Frohnert BI, et al. Roux-en-Y Gastric Bypass Acutely Decreases Protein Carbonylation and Increases Expression of Mitochondrial Biogenesis Genes in Subcutaneous Adipose Tissue. Obesity surgery. 2015 Dec;25(12):2376–85. doi: 10.1007/s11695-015-1708-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Moreno-Castellanos N, Guzman-Ruiz R, Cano DA, et al. The Effects of Bariatric Surgery-Induced Weight Loss on Adipose Tissue in Morbidly Obese Women Depends on the Initial Metabolic Status. Obesity surgery. 2016 Aug;26(8):1757–67. doi: 10.1007/s11695-015-1995-x. [DOI] [PubMed] [Google Scholar]
  • 118.Camastra S, Vitali A, Anselmino M, et al. Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery. Scientific reports. 2017 Aug 21;7(1):9007. doi: 10.1038/s41598-017-08444-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Martinez de la Escalera L, Kyrou I, Vrbikova J, et al. Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery. BMC Medicine. 2017 Feb 16;15(1):34. doi: 10.1186/s12916-017-0797-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 2006 Dec;27(7):728–35. doi: 10.1210/er.2006-0037. [DOI] [PubMed] [Google Scholar]
  • 121.Cheng Z, Almeida FA. Mitochondrial alteration in type 2 diabetes and obesity: An epigenetic link. Cell Cycle. 2014;13(6):890–7. doi: 10.4161/cc.28189. 02/12 11/20/received 01/13/revised 02/11/accepted. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Padidar S, Farquharson AJ, Rucklidge GJ, et al. Influence of increased adiposity on mitochondrial-associated proteins of the rat colon: A proteomic and transcriptomic analysis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2008 Sep 01;1782(9):532–41. doi: 10.1016/j.bbadis.2008.06.002. [DOI] [PubMed] [Google Scholar]
  • 123.Nimri L, Saadi J, Peri I, et al. Mechanisms linking obesity to altered metabolism in mice colon carcinogenesis. Oncotarget. 2015;6(35):38195–209. doi: 10.18632/oncotarget.5561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Yehuda-Shnaidman E, Nimri L, Tarnovscki T, et al. Secreted human adipose leptin decreases mitochondrial respiration in HCT116 colon cancer cells. PloS one. 2013;8(9):e74843–e. doi: 10.1371/journal.pone.0074843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Semple RK, Crowley VC, Sewter CP, et al. Expression of the thermogenic nuclear hormone receptor coactivator PGC-1alpha is reduced in the adipose tissue of morbidly obese subjects. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. 2004 Jan;28(1):176–9. doi: 10.1038/sj.ijo.0802482. [DOI] [PubMed] [Google Scholar]
  • 126.Toledo FG, Goodpaster BH. The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging. Molecular and cellular endocrinology. 2013 Oct 15;379(1–2):30–4. doi: 10.1016/j.mce.2013.06.018. [DOI] [PubMed] [Google Scholar]

RESOURCES